Skip to main content
OpenTrials
Completed

NCT Number: NCT01142609

Improving Substance Abuse Counseling Adherence Using Web-based Videoconferencing

This research is being done to compare the effectiveness of standard on-site, in-person counseling with Internet web-based videoconferencing (e-therapy) in drug-dependent patients in opioid-agonist treatment programs. The study is looking to see if there are any differences in satisfaction or in treatment outcome if counseling sessions are given by e-therapy compared to standard, in-person counseling given in the clinic. The e-therapy happens in real time- it works very much like standard therapy in the clinic except that the patient is in his or her own home (or other convenient location outside the clinic) and talks to and sees the therapist through an Internet connection on the computer (the therapist will usually be at the clinic).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance Abuse Disorder Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Addiction Treatment Services

Baltimore, Maryland, 21224, United States

About this study

This study will be the first to evaluate the efficacy of an accredited and currently available, Internet web-based videoconferencing platform to deliver routine schedules of counseling in an opioid agonist treatment program. It has outstanding potential to help determine transportability of this technology to other treatment programs by demonstrating the benefits of integration of web-based therapy with on-site services to expand the continuum of care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Access to a computer with Internet capability
  • Full adherence to their routine counseling schedule over the previous 30-days
  • Negative urine specimens over the previous 30-days
  • Patient at ATS for 90 days

Exclusion criteria

  • No access to a computer with Internet capability

Treatment and study plan

eGet

Behavioral

eGet individual counseling sessions from home will be scheduled weekly for 12 weeks.

Primary outcomes

  1. Counseling efficacy

    Time frame: Weekly for 12 weeks

    Attendance to individual counseling sessions, both online and on-site will be tracked weekly for the duration of the study.

  2. Reinforcement value (eGetgoing)

    Time frame: Monthly for 3 months

    Subjects will complete monthly surveys to evaluate the reinforcement value of eGetgoing using a multiple choice design that will compare its perceived value to other aspects of routine treatment (e.g., take-home medications).

  3. Reinforcement value (on-site)

    Time frame: Baseline

    Subjects will complete a survey to evaluate the reinforcement value of eGetgoing using a multiple choice design that will compare its perceived value to other aspects of routine treatment (e.g., take-home medications).

Secondary outcomes

  1. Program Satisfaction

    Time frame: Baseline and monthly for 3 months

    Subjects will complete a survey to assess their overall program satisfaction

  2. Treatment cost

    Time frame: Baseline and Month 3

    Subjects will complete surveys to measure treatment related time and monetary travel costs.

  3. Therapeutic relationship

    Time frame: Baseline and monthly for 3 months

    Subjects and their therapists will complete surveys to assess qualities of the therapeutic relationship.

Sponsors and collaborators

Lead sponsor

Johns Hopkins University

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Jun 11, 2010
Registry last updated
Apr 4, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.